drugset / Trial / NCT01929031

Efficacy and Safety of Ibuprofen and Caffeine in Dental Pain

NCT01929031 ↗

Phase 3 Completed 562 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of this study is to compare the efficacy of a combination product containing ibuprofen 400 mg and caffeine 100 mg versus either ingredient alone as well as placebo for the treatment of post-surgical dental pain over an eight-hour period followed by a single dose of study medication (study stage 1). A secondary objective is to evaluate efficacy of multiple doses of the combination in comparison to ibuprofen alone over a 5-day post-surgical period (study stage 2).

Timeline

Start
2013-08
Primary completion
2014-03
Completion
2014-03

Outcome

Met primary endpoint

registry analysis (superiority or other test); Ibuprofen vs Ibuprofen/Caffeine; p <0.0001; Mean Difference (Final Values) 12.126 (95% CI 6.493 to 17.759); ANCOVA NCT01929031 ↗

paper Analysis of SPRID0-8 h demonstrated superior analgesic effects for a single dose of ibuprofen/caffeine versus ibuprofen, caffeine and placebo over 8 h PMID 28805281 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule 100 mg —
Subject Ibuprofen Small molecule 400 mg —